Serum expression signature of TUG1, MALAT1, miR-483, and miR-141 and their targets TGF-β1 and STAT3 in severe male factor infertility

Long non-coding RNAs and microRNAs have evolved as biomarkers and specific therapeutic targets for male infertility. We investigated the seminal plasma and serum expression profiles of TUG1, MALAT1, miR-483, and miR-141 and their targets TGF-β1 and STAT3 in severe male factor infertility. The potential of their serum levels as minimally invasive, clinically accessible, and more feasible biomarkers and their clinical correlations were explored. Thirty non-obstructive azoospermia (NOA) patients, 30 severe oligozoospermia (SO) patients, and 30 healthy fertile men (controls) were enrolled. Compared to controls, seminal plasma and serum TUG1 and miR-141 were downregulated; meanwhile, miR-483 and STAT3 were upregulated in both NOA and SO patients, while MALAT1 was upregulated in NOA but downregulated in SO patients. Seminal plasma TGF-β1 was higher in NOA patients than in controls and SO patients, while its serum levels were not statistically different between the studied groups. NOA patients showcased higher serum STAT3 mRNA expression than SO patients. Seminal plasma and serum levels of most of the tested markers were correlated among NOA and SO patients. Multivariate logistic analysis unraveled the association of serum TUG1 and miR-141 with NOA risk and serum TUG1 and miR-483 with SO risk. A serum-based panel of TUG1/miR-141 and TUG1/miR-483 discriminated NOA (AUC = 0.93) and SO (AUC = 0.972) from controls, respectively. Serum miR-141 was correlated with the hormonal profile in NOA patients. In SO patients, serum TUG1 was correlated with total testosterone levels and abnormal sperm motility, while serum MALAT1 was inversely correlated with the testicular volume. Conclusively, this study introduces a novel serum-based prediction panel of TUG1/miR-141 and TUG1/miR-483 to help enhance the accuracy of NOA and SO diagnosis. Serum MALAT1 and STAT3 could be useful in stratifying NOA and SO. These findings warrant more future investigations for their possible implication in male infertility diagnostics.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2025-05-27
DOI
https://doi.org/10.1038/s41598-025-03231-0
Citations
5
Primary Topic
Sperm and Testicular Function
Type
article
Field-Weighted Citation Impact
8.49

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Serum expression signature of TUG1, MALAT1, miR-483, and miR-141 and their targets TGF-β1 and STAT3 in severe male factor infertility

Mahmoud A. Senousy, Ghada Ayeldeen, Olfat Gamil Shaker, Nesreen M. Aboraia et al.
5 citations
Scientific Reports
Sperm and Testicular Function
8.49
article

Serum expression signature of TUG1, MALAT1, miR-483, and miR-141 and their targets TGF-β1 and STAT3 in severe male factor infertility

Mahmoud A. Senousy, Ghada Ayeldeen, Olfat Gamil Shaker, Nesreen M. Aboraia, Ahmed Gamal
article en
5 citations

Abstract

Long non-coding RNAs and microRNAs have evolved as biomarkers and specific therapeutic targets for male infertility. We investigated the seminal plasma and serum expression profiles of TUG1, MALAT1, miR-483, and miR-141 and their targets TGF-β1 and STAT3 in severe male factor infertility. The potential of their serum levels as minimally invasive, clinically accessible, and more feasible biomarkers and their clinical correlations were explored. Thirty non-obstructive azoospermia (NOA) patients, 30 severe oligozoospermia (SO) patients, and 30 healthy fertile men (controls) were enrolled. Compared to controls, seminal plasma and serum TUG1 and miR-141 were downregulated; meanwhile, miR-483 and STAT3 were upregulated in both NOA and SO patients, while MALAT1 was upregulated in NOA but downregulated in SO patients. Seminal plasma TGF-β1 was higher in NOA patients than in controls and SO patients, while its serum levels were not statistically different between the studied groups. NOA patients showcased higher serum STAT3 mRNA expression than SO patients. Seminal plasma and serum levels of most of the tested markers were correlated among NOA and SO patients. Multivariate logistic analysis unraveled the association of serum TUG1 and miR-141 with NOA risk and serum TUG1 and miR-483 with SO risk. A serum-based panel of TUG1/miR-141 and TUG1/miR-483 discriminated NOA (AUC = 0.93) and SO (AUC = 0.972) from controls, respectively. Serum miR-141 was correlated with the hormonal profile in NOA patients. In SO patients, serum TUG1 was correlated with total testosterone levels and abnormal sperm motility, while serum MALAT1 was inversely correlated with the testicular volume. Conclusively, this study introduces a novel serum-based prediction panel of TUG1/miR-141 and TUG1/miR-483 to help enhance the accuracy of NOA and SO diagnosis. Serum MALAT1 and STAT3 could be useful in stratifying NOA and SO. These findings warrant more future investigations for their possible implication in male infertility diagnostics.

Scientific ReportsVol. 15(1)
Cairo University (EG)
Cairo University
Reduced inequalities
Openalex Percentile: Top 2%
Sperm and Testicular Function
8.49
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.